Study Uncovers Link Between Brain Inflammation and Muscle Weakness

Research identifies IL-6 protein as a key player in muscle dysfunction across various diseases, offering new treatment avenues.

Brain inflammation releases IL-6 protein, reducing energy production in muscle cells.
IL-6 travels from the brain to muscles, impairing their function.
The study used disease models including E. coli, SARS-CoV-2, and Alzheimer's.
Blocking the IL-6 pathway could prevent muscle weakness in affected patients.
Existing drugs targeting IL-6 and JAK-STAT pathways show potential for treatment.